4.5 Article

Pentoxifylline for treatment of major depression after percutaneous coronary intervention or coronary artery bypass grafting: A randomized, double-blind, placebo-controlled trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Neurosciences

Neuroinflammation and depression: A review

Romain Troubat et al.

Summary: Neuroinflammation interacts with key neurobiological factors of depression, potentially presenting a crucial therapeutic target for future treatments. This interaction may impact serotonin levels, HPA axis regulation, and hippocampal neurogenesis, leading to the pathophysiological cascade of increased glutamate levels and altered neurotransmission. It can be triggered by chronic inflammatory conditions or primary brain neuroinflammation, highlighting the importance of addressing neuroinflammation in the treatment of major depressive disorder.

EUROPEAN JOURNAL OF NEUROSCIENCE (2021)

Article Clinical Neurology

Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment

Ashley N. Siegel et al.

Summary: PTX, as a promising pleiotropic agent, shows potential novel mechanisms in treating mood disorders, which need further evaluation in clinical trials.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)

Article Pharmacology & Pharmacy

Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial

Mostafa Farajollahi-Moghadam et al.

Summary: The study showed that the combination therapy of pentoxifylline with sertraline is effective and safe in treating major depressive disorder (MDD). The group receiving sertraline plus pentoxifylline demonstrated greater improvement in depression scores compared to the sertraline plus placebo group. Additionally, response to treatment rate was significantly higher in the group receiving the combination therapy.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2021)

Review Clinical Neurology

Phosphodiesterase-5 inhibitors: Shedding new light on the darkness of depression?

Eduardo Duarte-Silva et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Review Pharmacology & Pharmacy

Role of oxidative stress in depression

Shvetank Bhatt et al.

DRUG DISCOVERY TODAY (2020)

Review Cardiac & Cardiovascular Systems

Depression and coronary heart disease

Robert M. Carney et al.

NATURE REVIEWS CARDIOLOGY (2017)

Article Biochemistry & Molecular Biology

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants

Ronald S. Duman et al.

NATURE MEDICINE (2016)

Review Cardiac & Cardiovascular Systems

Pentoxifylline for vascular health: a brief review of the literature

Mark F. McCarty et al.

OPEN HEART (2016)

Article Cardiac & Cardiovascular Systems

Pentoxifylline in Heart Failure: A Meta-Analysis of Clinical Trials

Sebastien Champion et al.

CARDIOVASCULAR THERAPEUTICS (2014)

Article Behavioral Sciences

Pretreatment with pentoxifylline has antidepressant-like effects in a rat model of acute myocardial infarction

Thierno Madjou Bah et al.

BEHAVIOURAL PHARMACOLOGY (2011)

Article Medicine, General & Internal

Depression and heart rate variability in patients with coronary heart disease

R. M. CARNEY et al.

CLEVELAND CLINIC JOURNAL OF MEDICINE (2009)

Review Clinical Neurology

Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial

Shahrokh Amiri et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)

Article Cardiac & Cardiovascular Systems

Course of depressive symptoms and medication adherence after acute coronary syndromes -: An electronic medication monitoring study

Nina Rieckmann et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Article Cardiac & Cardiovascular Systems

Pentoxifylline affects cytokine reaction in cardiopulmonary bypass

Ihsan Iskesen et al.

HEART SURGERY FORUM (2006)

Review Cardiac & Cardiovascular Systems

Depression in heart failure - A meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes

Thomas Rutledge et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Article Neurosciences

Impairment of endothelial function in unipolar and bipolar depression

Janusz K. Rybakowski et al.

BIOLOGICAL PSYCHIATRY (2006)

Article Health Care Sciences & Services

Prevalence of depression in survivors of acute myocardial infarction - Review of the evidence

BD Thombs et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2006)

Review Pharmacology & Pharmacy

Cardiovascular side effects of new antidepressants and antipsychotics: New drugs, old concerns?

P Pacher et al.

CURRENT PHARMACEUTICAL DESIGN (2004)

Article Cardiac & Cardiovascular Systems

Depression but not anxiety influences the autonomic control of heart rate after myocardial infarction

MV Pitzalis et al.

AMERICAN HEART JOURNAL (2001)